Catalyst Wire Dossier Catalyst Wire Dossier

risperidone (injectable)

risperidone · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for risperidone (injectable), covering 2009-02-27 to 2009-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes [Phase 3]

See pricing